Dolca Rogers European Medicines Agency

Scientific administrator at the European Medicines Agency (EMA) since 2018 providing scientific support for initial Marketing Authorisations, variations and scientific advice procedures as well as input in support initiatives of the EMA with a special focus on ATMPS. Working for the Pharmaceutical Quality Office (CMC) and the Advanced Therapies Office as Topic Lead for Advance Therapy Medicinal Products. Before joining the Agency, she worked in research and development of new pharmaceutical products, from small molecules, antibodies to cell products. Experienced in CMC Regulatory Affairs in the pharmaceutical industry and in consultancy. Master’s Degree from the University of Barcelona and PhD in drug delivery systems for skin by Queen Mary University of London.